Page last updated: 2024-08-25

dienogest and Bone Loss, Osteoclastic

dienogest has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gräser, T; Janaud, A; Römer, T; Wiedey, KD	1

Trials

1 trial(s) available for dienogest and Bone Loss, Osteoclastic

Article	Year
Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints. Climacteric : the journal of the International Menopause Society, 2001, Volume: 4, Issue:4 Topics: Aged; Bone Resorption; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Endometrium; Estradiol; Europe; Female; Follicle Stimulating Hormone; Hormone Replacement Therapy; Hot Flashes; Humans; Lipoproteins; Middle Aged; Nandrolone; Patient Satisfaction; Postmenopause; Triglycerides; Ultrasonography; Uterine Hemorrhage	2001

Article

Year

Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints.

Climacteric : the journal of the International Menopause Society, 2001, Volume: 4, Issue:4

Topics: Aged; Bone Resorption; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Endometrium; Estradiol; Europe; Female; Follicle Stimulating Hormone; Hormone Replacement Therapy; Hot Flashes; Humans; Lipoproteins; Middle Aged; Nandrolone; Patient Satisfaction; Postmenopause; Triglycerides; Ultrasonography; Uterine Hemorrhage

2001